Organicell Regenerative Medicine (OTCBB: BPSR), a clinical-stage biopharma company developing exosome-based regenerative therapies, has announced the release of a Case Report in the peer reviewed journal Frontiers in Medicine. This case study highlights the therapeutic potential of Organicell’s proprietary therapeutic, Zofin™, and its continued success as a drug candidate. [Read more…]
Celonic to Expand Cell and Gene Therapy CDMO Business with Facility in Switzerland
Celonic to Boost Its Cell and Gene Therapy (CGT) Production with a Facility in the Upcoming Life Science Parket Rheintal, located in Stein, Switzerland.
Celonic Group, a leading global CDMO specializing in the development and production of Advanced Therapy Medicinal Products (ATMP) and bio-therapeutics, announced a long-term lease agreement for a new production site and office space. The facility will span 91,500 square feet (8,500 sqm) in the WST-222 building at the Novartis-operated Life Science Park Rheintal. [Read more…]
Pharmaron Acquires State-of-the-Art Biomanufacturing Site in the United Kingdom from AbbVie
Pharmaron Continues to Expand Its Capacity to Offer Commercial Manufacturing Services for CGT Products
February 28, 2021, BEIJING–Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) has entered into a definitive agreement to acquire Allergan Biologics Limited (“The ABL site”) in Liverpool, UK, for US$118.7 million in cash from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions. [Read more…]
WuXi AppTec Acquires OXGENE as Its First Cell & Gene Therapy Manufacturing Facility in Europe
WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology and medical device industries, announced that it has completed the acquisition of OXGENE, a pioneering United Kingdom-based contract research and development organization that designs and develops scalable gene therapy technologies. This acquisition enables WuXi AppTec to offer its customers end-to-end support in the creation and development of cutting-edge cell and gene therapies for patients in need worldwide. [Read more…]
Kimera Labs Introduces the Ross Unit, a Standard Measurement for Exosome Potency and Characterization
Although long overlooked, exosomes have been gaining momentum due to their potential for use as cell-free therapeutics. Exosomes are small vesicles ranging from 30-100nm in size that are found in nearly all eukaryotic fluids and facilitate a range of important cellular functions. They transfer DNA, RNA, and proteins to other cells, thereby altering the function of the targeted cells. [Read more…]
- « Previous Page
- 1
- …
- 174
- 175
- 176
- 177
- 178
- …
- 339
- Next Page »